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Sufficient tissue trauma produces a temporary rise in circulating concentrations of various 
tissue proteins including creatine kinase (CK), myoglobin (Mb), myosin heavy chain (MHC), 
and collagen metabolites, as well as acute phase inflammation related analytes such as C-
reactive protein (CRP), and the cytokines, interleukin-6 (IL-6) and interleukin-8 (IL-8) that 
mark the presence or absence of an injury or inflammatory response. Chronic, or late, 
elevations in biomarkers may also correlate with surgical complications. Measurement of 
biomarkers in orthopedic surgeries has been undertaken for 2 purposes: 1) to evaluate 
surgeries per se for improvement of surgical techniques and reducing adverse 
consequences, and 2) to examine measurement properties of biomarkers, using surgeries as 
models of musculoskeletal trauma and inflammation. In this chapter, some of the findings 
are described to illustrate both research objectives and their inter-relatedness, and to a 
degree, to capture aspects of the state of development of the overall biomarker research 
paradigm for surgical musculoskeletal injuries. The cytokine, interleukin-6 and the muscle 
cytoplasmic protein, creatine kinase, are emphasized partly because of known physiology 
and the relatively greater volume of research on these biomarkers over other candidates. 
However, some available research comparing these biomarkers with others is shown which 
has provided early evidence to substantiate better measurement characteristics for at least 
some applications. The survey is largely restricted to circulating blood concentrations over 
other possibilities (e.g. urine, joint synovial fluid, saliva) to allow comparison across studies, 
and given the potential for easier research and clinical application with venipuncture in 
comparison to joint fluid analysis, but not out of a lesser importance of investigations of 
other body fluids. Joint arthroplasty and lumbar surgery are the main focus since other 
surgeries (e.g. arthroscopy) produce much less tissue disruption and might be better studied 
by local tissue or fluid sampling, and because surgeries in emergency settings (e.g. fracture 
reduction) involve a more complex biochemical response post-surgery created by the 
combination of the original injury and the surgical injury. Findings from orthopedic 
surgeries are given priority but findings from non-orthopedic surgeries are shown when 
there is a difference in measurement principles or when measurement properties or clinical 






2. Measurement properties 
2.1 Basic physiology 
Historically, basic and applied physiology studies implicated a large number of proteins as 
potential markers of tissue injury, injury related inflammation, and inflammation created 
during injury by secondary causes such as infection or stress responses (Bauman 1994; 
Febarraio & Pederson 2005; Fong et al 1990; Jakab & Kalabay 1998; Wu & Perryman 1992). 
In the early, pro-inflammatory, stages of the response to trauma, monocytes and 
macrophages release IL-6, TNF-alpha, and IL-1beta. TNF-alpha and IL-1beta have feed 
forward effects on endothelial cells and fibroblasts to also release IL-6, which is produced in 
these cells. While all 3 proteins could be markers of trauma, IL-6 was found to be the most 
potent inducer of the liver acute phase proteins including CRP and has captured much of 
the interest in injury research since that time (Heinrich et al 1990). IL-6 was named in 1987 
based on studies aimed at isolating a hepatocyte stimulating factor (Poupart et al 1987; 
Yasukawa et al 1987).  
CK is found in the muscle cytoplasm and is involved in the conversion of adenosine 
triphosphate to adenosine diphosphate during the energy transfer process. Separate 
isoforms exist for skeletal muscle (CK-MM), cardiac muscle (CK-MB) and brain (CK-BB). 
This specificity for skeletal muscle has advantages over other analytes such as MB and MHC 
which do not have separate cardiac and skeletal muscle isomers. Musculoskeletal trauma 
studies have measured either the total CK or CK-MM but the total circulating CK has 
invariably been found to consist almost exclusively of CK-MM (Kawaguchi 1996, 1997; 
Strecker et al. 1999; Kumbhare et al. 2007) in non-cardiac research.  
Given the large number of biomarkers being measured in clinical studies, short-listing to a 
manageable number of analytes that are most typically effective would be useful. Apart 
from the kinetics of biomarkers in circulation, other factors affecting the usefulness of 
biomarkers include the relative stabilities of proteins at room temperature, when frozen, and 
after repeated freeze thaws, as well as all of the measurement properties characteristic of the 
chemistry assays such as upper and lower detection limits, coefficients of variation, and the 
ability of the assay to recover/capture the true protein concentrations in the sample.  
Studies of the rapidly changing acute stage biochemical markers have reported differences 
in the magnitudes of peak concentrations, the statistical significance of a protein change, and 
the timing of the peak. Such differences require careful analysis to establish what is 
consistent, as part of the development of the biomarker paradigm. 
2.2 Response sensitivity 
Many pioneering studies have focused partly on the simple question as to whether a reliable 
biochemical response is achievable with one or more proteins. The sensitivity of a response, 
while relevant to diagnostic accuracy, is not the same thing, the latter requiring accurate 
placement of patients in the clinically positive group, and the clinically negative group.  
Two very early studies on lumbar surgery without fusion or instrumentation, found a 
serum mean CK-MM response of just over 500 U/L for single level posterior surgery, which 
was over 4 times the baseline CK-MM levels (Kawaguchi et al. 1996, 1997).  
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Injury responses to lumbar decompression with spinal instrumentation were studied 
including CRP and the cytokines IL-1ra, IL-6, IL-8, IL-10, TNF-RI, TNF-RII (Takahashi et al., 
2001). With sampling 1, 2, and 7 days following lumbar surgeries, IL-6, IL-8, and IL-10 were 
elevated only in a decompression plus spinal instrumentation group (n = 7) and not in 
groups having decompression only (n = 7) or decompression plus fusion (n = 6) although 
there appeared to be trends towards increases in these biomarkers in these less invasive 
surgeries. Given the likelihood that the biochemical responses are smaller to less invasive 
surgeries, small sample sizes may have prevented injury detection. In a subsequent study, 
involving 12 subjects and more serial measures, a significant increase in mean IL-6 was 
obtained at 6 hours following lumbar decompression (Kumbhare et al., 2009) with trends 
toward significant elevations at 12 and 24 hours. The IL-6 response was weaker than CK, 
consistent with the previous research showing an easily detected CK response but more 
difficult to detect rise in IL-6 in the lumbar decompression model. A similar study on CK 
showed excellent separation of the distributions of proteins for baseline to peak, versus 
baseline fluctuations (Kumbhare et al., 2007) showing sensitivity to lumbar decompression. 
The reduced sensitivity of IL-6 to muscle trauma, in comparison to CK could be related to 
the degree to which IL-6 is inducible in muscle. Examination of tissue homogenates found 
greatest concentrations of IL-6 in bone and lung, lower concentrations in skin and adipose 
tissue, and lowest concentrations in skeletal muscle (Perl et al. 2003).  
In the instrumentation research (Takahashi et al., 2001, 2002), IL-8 and IL-10 were found to 
peak earlier than IL-6 such that the injury response was largely absent by the next day, 
whereas IL-6 remained elevated the day after surgery and had not resolved by day 2 post-
surgery. This suggested narrow diagnostic windows for IL-8 and IL-10, which could make 
these proteins more difficult to capture in sampling. 
Myosin heavy chain (MHC) has the advantage of a wider diagnostic window than CK or the 
pro-inflammatory cytokines. Yet, it has been studied very little in orthopedic research. MHC 
is a component of the contractile apparatus of muscle. Onuoha and coworkers (2001) 
measured serum MHC concentrations before fracture reduction and serially after the 
operation in a heterogenous group having various types of fracture surgeries. Twenty-four 
hours post surgery, group mean (n = 12) MHC concentrations showed an approximate 3-
fold increase over mean baseline concentration which was about 100 ug/L. This amounted 
to an effect size of about 3 standard deviations. MHC was argued to be a better marker than 
the traditional use of CK or myoglobin because the latter can increase in circulation with a 
leaky membrane only, whereas elevated MHC reflects destruction of the contractile 
mechanism and therefore, is more consistent with the concept of injury. In short, CK-MM 
has the advantage of skeletal muscle specificity, whereas MHC  of specificity to the state of 
injury may be more specific to the state of injury. 
Munoz et al (2005) compared biomarker responses following spinal instrumentation 
surgery with serial measures at pre-operation, post-operation, 1 day, 2 days, and 7 days. 
They measured a wide range of potential biomarkers including CRP and IL-6 as well as 
IL1b, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12, TNF-alpha, and interfeuron-gamma. Only CRP 
and IL-6 showed sensitivity to the surgical trauma. Similarly, a study of total knee 
replacement (TKR) in Britain, found no serum injury responses for TNF-alpha (Andres et 
al., 2003) at 6, 24, or 48 hours following total knee arthroplasty and IL-1beta was elevated 






in joint drain fluid. Given that TKR produces biochemical changes that are quite large in 
comparison to other surgeries, analysis of circulating TNF-alpha and IL-1beta have not 
been supported as general indices of the pro-inflammatory response with the current 
chemistry assays when circulating concentrations are used. TNF-alpha and IL-1beta may 
be useful for analyses on joint fluid. TNF-alpha was found to be elevated in circulation for 
short bursts among patients hospitalized for sepsis (Damas et al., 1992). IL-1 beta was not. 
However, even in that study, persisting IL-6 elevations were not only easier to measure by 
virtue of their longer time course in fluctuations, but allowed greater prediction of shock 
than TNF-alpha.  
In a British study (Hall et al., 2000) a factor analysis was used to examine the temporal pattern 
of a number of proteins including IL-6, CRP, and cortisol. The cortisol response started earliest 
and had returned to baseline by about 48 hours and was only about 50% higher than baseline 
at 24 hours showing less response magnitude and a shorter time course than IL-6 or CRP. 
Separate independent factors were created by the distinctly different time x magnitude profiles 
for these 3 proteins. This contrasted with the use of epinephrine and norephineprine, which 
were inter-correlated implying redundancy in measurement. The findings demonstrated a 
need for separate time series protocols when studying these different proteins.  
The routine availability of a biomarker is a practical advantage and must be weighed against 
measurement properties of proteins that might be expensive to measure or measurable only 
in specialty laboratories. For example, IL-6 has frequently been considered to be preferable 
to CRP for measurement of early phase inflammation. However, while this seems more 
evident for some applications, a more general superiority of IL-6 over other candidates 
cannot yet be concluded. The fact that CRP is routinely available in many clinical 
laboratories, whereas IL-6 requires purchasing or developing immunological assays forces a 
need for evidence of sufficient superiority. The fact that clinical research might become 
applied more quickly and easily in the case of CRP is relevant. One example is a study on 
post-surgery infection (DiCesare et al., 2005) following TKR and THR. The statistical effect 
size for group differences were just over 1 standard deviation for all 3 significantly elevated 
proteins (Il-6, CRP, ESR) showing no relative advantage of IL-6 for separating the infected 
and non-infected distributions with the exception of a slightly weaker group separation by 
CRP in the THR patients created by a high standard deviation in the infected group. In an 
earlier study, that also involved hip and knee arthroplasties, the acute phase responses for 
IL-6 and CRP had similar effect sizes, amounting to roughly 2.5 standard deviation increases 
over baseline (Wirtz et al., 2000).  
Outside of orthopedic surgery research, superiority of IL-6 over CRP has been reported. For 
example, IL-6 and procalcitonin levels were higher in the presence of episodes of bacteremia 
in neutropenic patients with hematological malignancies. CRP was elevated in the 
population but showed no correlation with the presence of bacteremia (von Lilianfield-Toll 
et al., 2004). The quicker return to baseline by IL-6 over CRP is a particular advantage in 
such situations, where the clinical condition fluctuates over time.  
2.3 Time course 
Surgery models offer the advantage of a pre-surgery baseline. In knee and hip arthroplasty, 
typical periods of hospitalization allow for control while sampling in the sensitive time 
windows for most of the biomarkers studied to date.  
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Evaluation of biomarker time courses requires multiple serial measures. Studies differ 
substantially on serial measurement, ranging from a single post-injury sample, to many time 
points, and all studies do not include pre-surgery or late enough time points to establish 
baselines and return to baseline. Therefore, there has been a limited ability to clarify the 
sensitive time windows and more precision is required. 
Two early studies provided multiple serial measures to capture biomarker time-sensitive 
windows for inflammation related proteins. Wirtz et al (2000) included pre-operative and 
post-operative sampling at 6 and 12 hours and at daily intervals to 1 week following hip (n 
= 20) and knee (n = 10) arthroplasties. They compared the IL-6 time course with CRP. This 
revealed a slower rise in CRP relative to IL-6 and a much slower decline such that group 
peak CRP was reached between 1 to 2 days after surgery and remained about two-thirds of 
peak at 4 days and had not returned to baseline by day 7. IL-6 showed re-established 
baseline by about 3 days. The authors noted that other research showed the return to 
baseline for CRP is about 3 weeks, and ESR requires about 3 months. Therefore, an unusual 
persistent post-surgical elevation would be evident sooner with IL-6.  
A second study (Hall et al 2000) included many serial data points and a relatively large 
sample (n = 158) of subjects who had either TKR or THR. Samples were taken before and 
after surgery prior to tourniquet release, and at 2, 4, 8, 12, and 24 hours and then daily to 7 
days. Peak IL-6 occurred at 24 hours, whereas the CRP peak occurred at 48 hours. IL-6 
returned to baseline more quickly than CRP. However, smaller but significant elevations in 
both proteins were still present on day 7. In other words, the pattern of relative changes in 
IL-6 and CRP were consistent with other research.  
However, these 2 studies showed outcome differences of potential importance. First, the 
mean protein concentrations do not coincide. Wirtz et al obtained a peak IL-6 of about 400 
pg/ml in each of the TKR and THR groups. Peak CRP was about 150 mg/L in each group. 
In the Hall study, peak IL- 6 was 125 pg/ml after THR and 175 pg/ml after TKR. The teams 
used different chemistry assays for both proteins. Whether these dramatic differences are 
related to assay sensitivities, differences in drugs used in the different study locations, or 
other factors is not known. The use of different assays and different clinical protocols in 
different jurisdictions may be sources of variability in biochemical studies.  
Comparisons between proteins on peak timing need to take individual differences into 
account. In a protocol aimed at defining the time course for CK and IL-6, serial measures 
were made before and immediately after lumbar decompression surgery and at 6, 12, 24, 48, 
at and 72 to 96 hours, and at 7 days (Kumbhare et al., 2007, 2009). The highest CK 
concentration occurred at different time points between 12 to 48 hours across subjects and 
the highest IL-6 concentration had a range of 6 to 24 hours. Time related individual 
differences create enough variance that this could affect various conclusions. For example, 
differences between 2 equally effective biomarkers on their prediction of clinical outcomes 
could be created by how closely sampling is done to the average peaks for each protein, or 
variability in peak timing within proteins in the subject sample.  
2.4 Validity 
The search for validity has been somewhat of a challenge because of the difficulty finding 






none. For example, unaccustomed exercise produces a well documented rise in CK (Critz & 
Cunningham 1972) and IL-6 (Petersen & Pederson 2005; Steensberg 2003). Bicep curls with 
both arms produced no greater change in CK than exercise at the same weight load, in one 
arm (Nosaka et al., 1992, 2002). Such findings could reflect a relative lack of biomarker 
sensitivity to injuries of different magnitude. Findings from some orthopedic studies 
involving direct validity quantification have produced more promising results. In a similar 
demonstration (Kugisaki et al., 2011), unilateral TKR was compared with bilateral TKR. The 
serum peak IL-6 for bilateral TKR was 246% of the peak for unilateral TKR. While a perfect 
outcome would be 200% difference, the design was between subjects by necessity and 
therefore individual differences might account for the relatively greater than double 
biochemical response in the bilaterals. Bilateral TKR produced only a 146% increase in CRP 
compared to unilateral TKR providing some evidence that CRP may be less sensitive 
creating less validity for detecting varying amounts of injury.  
In studies of orthopedic and non-orthopedic surgeries, circulating IL-6 concentration was 
correlated with length of operation (Sakamoto 1994), amount of blood loss (Sakamoto 1994), 
and patients with higher blood loss requiring transfusions had higher IL-6 as a group in 
comparison to those with blood loss under 400ml and not requiring transfusions (Avall et al 
1999). Studies described later in this chapter showing correlation of IL-6 responses with 
body temperature and post-operative pain provide further convergent type validity 
evidence (Lisowska et al. 2006).  
In lumbar surgery, 7 patients with decompression plus instrumentation had higher post-
surgery biomarker concentrations in comparison to 7 subjects who had decompression 
alone. Decompression plus fusion (n = 6) showed an intermediate biochemical response 
(Demura et al., 2006). In an older study (Kawaguchi et al., 1996), the CK-MM response was 
higher in patients with multiple level surgery (n = 14) in comparison to single level (n = 10). 
In the same study, dividing the group into greater retraction forces (retraction pressure x 
retraction time) and lesser forces revealed a higher CK-MM in the greater force subgroup. 
However, this could have been related to a higher proportion of multilevel surgeries in the 
greater force group given longer surgery times. Accordingly, in this team’s subsequent 
report on a larger sample (n = 47) multilevel surgery continued to produce a higher CK-mm 
response than single level, but separate analysis of surgery time showed no increased CK-
MM in the subgroup having longer surgery times compared to shorter duration of muscle 
strain (Kawaguchi et al., 1997). They also found no difference between 2 subgroups 
separated on the basis of the length of the incision.  
To further explore the potential for developing a criterion measure in lumbar surgery, the 
length and depth of the muscle isolated and retracted (i.e. surface area) was used as a 
criterion measure for validity examination in 18 subjects who underwent lumbar 
decompression (Kumbhare et al., 2008). Rather than divide the sample into subgroups, the 
correlation was examined continuously against individual peak serum CK. Muscle surface 
area and peak CK response had a Pearson r correlation of .60, falling in a moderate range. 
2.5 Summary 
Studies of basic measurement properties have largely involved relatively small samples. 
This is partly related to the need for many serial samples creating many data points. 
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Therefore, the extent to which the findings on kinetics of biomarkers generalize across 
subjects partly remains to be determined. Practical barriers make it impossible to sample 
precisely time-wise. Data presentations frequently use such increments as “Day 1, Day 2”, 
acknowledging such imprecision. It is therefore difficult to know exactly when samples 
were taken, and therefore difficult to extract the true time course. Muscle proteins have been 
studied less often than inflammation proteins and with smaller sample sizes, so relatively 
less is known about measurement properties in application to surgeries. Use of some 
proteins as general markers is weakened by relatively low sensitivity or short time courses. 
CK appears to be quite sensitive to surgical muscle trauma being consistently elevated even 
with low trauma surgery. Among the inflammation related markers, IL-6 and CRP have 
shown robustness in comparison to other proteins, in that they consistently are elevated. 
Some evidence suggests that CRP is less sensitive than IL-6 as a general proinflammation 
marker but the differences between IL-6 and CRP have not been large. Time courses have 
not been entirely consistent across studies. This could be related to difficulties timing 
sampling or to individual differences in time to peak. It seems likely that validity is in a 
moderate rather than high range in general. This could be related to variance created by: i. 
variability in sample timing within and between studies, or ii. the choice of criterion 
measures which may only approximate the construct of interest. Not discussed in this 
chapter are confounds and patient characteristics that may vary across individuals such as 
gender, age, body mass, anesthetics and other pharmacological agents, comorbidity, 
dehydration, activity levels, and other lifestyle factors. In fact, it may be unrealistic to expect 
better than moderate correlations between biomarkers and clinical outcomes.  
These basic measurement issues must be kept in mind when one is considering the reasons 
for various findings of studies that examine clinical applications of the biomarker paradigm, 
and the challenges faced when attempting to obtain precise prediction. 
3. Surgery evaluation, complications, and outcomes 
Non-orthopedic studies have included a range of surgeries including: cardiac (Antunes et 
al., 2008; Booth et al., 2010), aortic (Baigrie), stomach (Aguilar-Nascimento et al., 2007; 
Herrera et al., 2010), bowel (Herroeder et al., 2007 ), liver (Gravante et al., 2010; Sato et al., 
1996), hernias (Correla et al., 2001), cholesystemctomy (Chambrier et al., 1996; Kristiansson 
et al, 1999) and various cancers (Veenhof et al., 2011). Among orthopedic studies, there are 
now a large number of reports involving the use of biochemical injury measures for risk 
screening including their use in attempts to identify post-operative fever, and infection. 
Smaller literatures focus on technique comparisons for amount of tissue disruption or 
amount of inflammation, application in predicting hardware failure, and shorter term post-
surgical recovery and hospital stay. 
3.1 Post-operative fever 
Post-operative fever has been of some interest in the biomarker paradigm. This is despite 
uncertainty about its clinical significance, leading to claims that it may simply be a normal 
response to surgeries (Andres et al., 2003, Pile 2006; Shaw & Chung 1999,). It has been 
argued that unusually high or prolonged post-operative fever is a risk factor for 






causes (Fanning et al., 1998) including: urinary tract infections, pneumonia, blood 
transfusions, infections at the wound, surgical site, intravenous catheter or created by the 
prosthesis, deep venous thrombosis, and C-deficile related to peri-operative antibiotics.  
Andres and coworkers (2003) sought to provide evidence that post-operative fever was 
caused by the acute phase inflammatory response after arthroplasty. Half of their sample of 
20 had early (first 3 days) post-operative temperatures in the febrile range (>38.5C). The 
mean IL-6 concentration was higher in this group than the afebrile group at 24 and 48 hours, 
supporting the hypothesis that fever reflects an unusually high inflammatory biochemical 
response in the post-surgery phase. This separation based on fever, was not evident in 
circulating measurements of TNF-alpha or IL-1beta. Positive correlations between IL-6 and 
post-operative fever were also reported by others (Frank et al., 2000; Miyawaki et al., 1998). 
However, none of the febrile patients in the Andres et al study had complications, implying 
that IL-6 levels might correlate with fever, but neither IL-6 nor fever is specific for 
complications. Moreover, Andres et al. (2003) cite studies showing poor associations 
between fever and various post-operative complications. Fever may not have sufficient risk 
stratification potential on its own. One idea is that the fever is more typically related to 
extravasated blood and cellular debris (Shaw & Chung 1999) following arthroplasty. These 
early findings suggested that a correlation between IL-6 in the early post-operative phase 
and complications might exist, but prove not to be very strong.  
3.2 Post-operative pain 
The inflammatory response has been thought to contribute to pain in the early post-
operative period leading to the hypothesis that treatment by antiinflammatories will reduce 
the acute phase response, reduce pain, and possibly improve return to functioning. There 
has been a consistent improvement in post-operative pain when various antiinflammatories 
are administered prior to operations. For example, intravenous diclofenac reduced post-
operative pain and use of analgesics in a heterogenous sample having various surgeries 
(Claeys et al.1992). Naproxen reduced postoperative pain following knee arthroscopy (Code 
et al., 1994) and following spinal surgery (Munoz et al, 2004).  
In contrast, the effect of anti-inflammatories on the biochemical acute phase response has 
not been consistent. Using spinal surgery as a model, patients undergoing spinal fusion with 
instrumentation were assigned alternately to 2 groups of 20 subjects each, one that received 
500 mg/day of naproxen combined with 40 mg/day famotidine in an attempt to blunt the 
inflammatory response, or to a no anti-inflammatory treatment control (Munoz et al. 2004). 
Following the operation, patients who received the anti-inflammatory treatment had lower 
body temperatures and requested less analgesic. CRP was reduced substantially from a 
group peak of 18.2 mg/ml to 6.7 mg/ml. This pattern was similar to that found in a study 
with spinal surgery without instrumentation (Takahashi et al. 2001). However, there was no 
significant difference between the groups on the IL-6 response, despite the anti-
inflammatory pre-treatment. This contrasts with the finding of a reduction in the IL-6 
response, with no reduction in CRP, to peri-operative administration of ibuprofen in 
cholecystectomy (Chambrier et al., 1996). Finally, Diclofenic produced no reduction in the 
CRP response despite pre-treatment and 24 hours continuous infusion of the drug in their 
sample having various major surgeries (Claeys et al., 1992).  
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3.3 Infection, osteolysis and hardware loosening 
Studies examining the relationship between post-operative fever and infection have been 
reviewed for non-orthopedic surgeries (Fanning et al., 1998) and studies on knee and hip 
surgeries (Shaw & Chung 1999). The consistent result is that fever is an insufficient predictor 
of infection in non-orthopedic studies, which may be at least partly related to the high 
incidence of fever yet low rate of infection (Pile 2003). This has prompted the question as to 
whether biomarkers measured in the acute, early post-operative period, will generate the 
desired prediction.  
Studies on chronically elevated biomarkers, typically measured at the time of resection 
arthroplasty, have had some success. Serum IL-6 has been evaluated for association with 
periprosthetic infection specifically. Recent studies have included sensitivity and specificity 
evaluations, which become important if there is to be a clinical application. For example, 
DiCesare and coworkers(2005) compared the predictive relationships of IL-6, C-reactive 
protein (CRP), white blood cell count (WBC), and erythrocyte sedimentation rate (ESR). 
Fifty-eight patients requiring re-operation were separated into 2 groups, those with, and 
those without infection confirmed histologically. Blood sampling was done at a mean of 84 
months after the 1st operation, well after the acute elevations related to surgical injury would 
have resolved and baseline would be restored. Those with infection (n = 17) had higher 
concentrations of all 4 markers although WBC was not statistically significant. Using 10 
pg/ml or higher as the cut-off/criterion, IL-6 had perfect sensitivity (1.0) and close to perfect 
specificity (.95) meaning 1 subject was misclassified as infected who was not. CRP had 
poorer performance with a sensitivity of 94 specificity of .78. In the second study, Bottner 
and coworkers (2007) studied a larger sample of 78 subjects. Using a cut-off score of 12 
pg/ml (which is remarkably close to the cut-off in the previous study) IL-6 had a sensitivity 
of .95 but had a specificity of .87. CRP had the same sensitivity and .96 specificity. The 
combination of IL-6 > 12 pg/ml and CRP > 3.2 pg/ml correctly classified all patients. Such 
impressive accuracy has not always been obtained. In another study, IL-6 had a specificity 
of 1.0 when the cut-off was set to minimize false positives, but sensitivity was only 
modest at .57 (Buttaro et al, 2009). 
A recent review has focused on the association between biomarkers measured at clinical 
follow-ups following arthroplasty (Mertens& Singh 2001) and the incidence of hardware 
loosening, osteolysis, and infection at the site of prosthesis. In general, synovial fluid 
analyses produced stronger and more consistent separation of those with and without 
complications. In serum analyses, prosthesis loosening had the lowest potential for 
prediction. IL-6 showed no significant relationship in 2 studies. TNF-alpha and IL-1beta 
showed significant prediction in 1 of 2 and 1 of 3 studies respectively. Collagen I had better 
than chance prediction in 2 of 5 studies, with the suggestion that this might have been 
related to the different assays used. In osteolysis, serum collagen I was significantly higher 
in the affected group in 1 of 2 studies. No significant relationship was obtained for IL-6, 
CRP, TNF-alpha, or IL-1b in any of the studies. Performance of serum biochemistry was 
best, in general, in the case of infected prostheses. Significant correlations were obtained for 
IL-6 in 2 of the 2 available studies described individually earlier, CRP in 3 of 3 studies, ESR 
in 3 of 3 studies, and TNF-alpha in 1 of 1 study. Analyses on the degree of sensitivity and 






In a second review, sensitivity and specificity analyses were performed on data from 
multiple studies (Berbari et al., 2010) creating a pooled sensitivity, with focus on 
circulating protein concentrations. The review included three studies in which IL-6 was 
measured, and 23 on CRP, 25 with ESR measurements, and 15 having measured WBC. 
Pooled sensitivity and specificity were as follows: WBC .45 and .87, ESR .75 and .70, CRP 
.88 and .74, and IL-6 .97 and .91, suggesting that IL-6 produces the best association with 
infection. However, as described earlier, examination of individual studies, revealed that 
IL-6 had modest sensitivity in 1 study (Buttaro 200) in the presence of high specificity, and 
CRP had better specificity than IL-6 in another study despite equal sensitivity (Bottner et 
al. 2007). Sensitivity and specificity are influenced by the effect size of a group difference, 
which is a ratio of group mean differences to standard deviation. In small sample sizes, 
standard deviations can vary substantially from one study to another. Therefore, it is 
somewhat premature to conclude a superiority of IL-6 over CRP in the identification of 
infection.  
The possibility that biomarkers could help to time staged surgeries has been of recent 
interest. One model is repeat TKR following infection associated with the first procedure, 
whereby a 2nd surgery is performed to remove the hardware and cement, debride tissue, 
and insert a spacer block. The infection is then treated and re-implantation is performed 
when the infection is resolved. Given the promising evidence for an association between 
inflammation markers and infection, the question is raised as to whether these proteins 
could be used to judge when inflammation has been sufficiently controlled. Ghanem et al 
(2009) found no accurate relationship between either serum or joint fluid concentrations of 
C-reactive protein or erythrocyte sedimentation prior to re-implantation, and the rate of 
persisting infection following re-implantation. Investigation of other biomarkers was 
suggested. In a summary of conditions for re-implant timing, the authors do recommend 
including a return to normal CRP, which persists after discontinuing antibiotics, as one 
criterion for re-implanation. They also emphasize that this is insufficient and that other 
criteria should be used including, effective treatment of the potential source of the infections 
including resolution of urinary tract infections, cellulitis, poor dentition, or skin ulceration. 
Treatment of otherwise unwell patients (e.g. immunocompromised, malnourished) should 
be optimized before re-implantation, and there should be good healing of the soft tissues 
and resolution of erythema. 
3.4 Relative tissue disruption 
It has been argued that biomarkers may help to evaluate minimally invasive techniques 
against more traditional surgical approaches (Cohen et al., 2009 ; Hartzband et al., 2004) or 
against varying minimal trauma approaches under development.  
Chimento and coworkers (2005) compared their minimally invasive total hip arthroplasty 
procedure to the standard posterolateral approach. With the minimally invasive technique, 
the incision was 8 cm instead of 15 and smaller retractors were used. The technique also 
spared the quadratus femoris and the femoral insertion of the gluteus maximus. Circulating 
IL-6 concentrations did not differ between the 2 groups after surgery. However, the exact 
post-surgical time point was not reported. Given that the peak IL-6 concentrations were 
very low falling between about 5 pg/ml to 6.5 pg/ml in both the minimally invasive and 
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traditional surgery groups, the assay may have had low sensitivity or the sampling time 
may not have been near peak concentrations. 
In another study, a minimally invasive posterior approach that spared the quadrates femoris 
was compared to standard posterolateral approach to total hip arthroplasty (Fink et al., 
2010). There were no differences in circulating CK or Mb at 24 or 48 hours post-surgery, 
indicating that these proteins may not be sufficiently sensitive to the amount of affected 
muscle. 
Cohen and coworkers (2009) compared 3 approaches for hip arthroplasty, 1. minimally 
invasive Watson Jones technique, 2. miniposterior transmuscular approach, and 3. 
minimally invasive –II (MIS-II) incision. The first technique involves an anterior approach 
with no muscle detachment but muscle is retracted creating strain forces. The posterior 
technique involves a small incision and minimizes, but does not eliminate, muscle 
detachment. In MIS-II there is an anterior incision to access the acetabulum, and a posterior 
incision for passage of instruments. Muscle is separated or bypassed, but not cut or 
detached. The 3 techniques had mean incision lengths of about 10 cm, 9cm and 9cm 
(combined anterior + posterior) respectively. Serum Mb and CK showed injury responses in 
the first 24 hours that were just over double and 4 times the normal respectively. The 3 
techniques were not different in the magnitude of the biochemical response. However, 
group sizes of 10 were compared leading to the question as to whether larger samples could 
reveal subtle differences. 
3.5 Other adverse effects 
In their study described earlier, Cohen et al. found only 1 case in 30 of an elevated cardiac 
troponin following their minimally invasive hip replacement procedure. Cytokine responses 
were higher in patients who developed pancreatitis associated with spinal fusion surgery 
(He et al 2004). In a very recent study on mortality risk after hip fracture (Sun et al., 2011) IL-
6, TNF-alpha, and IL-10 were measured before surgical repair, 1hour after the operation, 
and at 1, 3 and 5 days. Thirty-one of the 127 patients had died by the 6 or 12 month follow-
ups. All 3 biomarkers showed significantly higher concentrations in the early post-surgical 
period in non-survivors. The best separation of the outcome groups was with IL-6 at 1 day 
post-surgery. Sensitivity and specificity analyses found IL-6 to be the best predictor. Setting 
the cut-off to minimize false negatives, IL-6 had a sensitivity of .935, but lower specificity at 
.635. This moderate level of prediction was also evident by the fact that the effect size of the 
group difference was about 1 standard deviation. This would imply a sizeable overlap in 
distributions. Nevertheless, the findings suggest that almost all of those who died could be 
predicted from the acute biochemical response while still reducing the total sample to a 
smaller high risk group that might be followed clinically.  
3.6 Early post surgical status and hospital length of stay 
Among non-orthopedic surgery studies, IL-6 on the day of haemopoietic stem cell 
transplantation predicted hospital length of stay (Tegg et al., 2001). Peri-operative lidocaine 
has been found to affect hospital length of stay for some abdominal surgeries. McCarthy 
(2010) reviewed studies in bowel surgery involving a total 395 treated patients and 369 






stay by an average 1.1 days. In contrast, lidocaine had no effect on length of stay following 
hysterectomy (Bryson et al., 2010).  
In a very recent study with 68 subjects having hip or knee arthroplasty (Koppensteiner et al., 
2001), both CRP and IL-6 in the acute phase, predicted the absence of complications during 
hospital stay. However, because IL-6 normalized faster, it provided the better criterion for 
safe discharge.  
3.7 Summary 
In general, circulating levels of biomarkers have been found to have considerably less 
sensitivity than measurement of these proteins in joint or drain fluids. Circulating chronic 
elevations in IL-6 and CRP have been found to be correlated with the development of 
infections with some promising sensitivity and specificity findings. There is some promising 
evidence for a predictive relationship between acute phase protein elevations and 
complications during hospitalization outside of orthopedic surgeries with an implication 
that proteins might be helpful in discharge decisions. The potential for affecting length of 
stay in orthopedic surgeries needs to be explored. Biomarker changes in the acute or chronic 
period have not been sufficiently sensitive to identify loosening of surgical hardware. 
However, a biomarker could increase in a similar manner to a range of pathologies, or 
increase only to some complications thereby helping with differential diagnosis. 
Accordingly, lower IL-6 might rule out infection leaving hardware loosening as a possibility 
thereby providing useful information. The potential for sensitivity to osteolysis has met with 
equivocal results but has not been ruled out.  
4. Summary and future directions 
The study of biomarker measurement properties with surgery models and their 
applications in surgery issues can be argued to be a relatively young paradigm, with the 
introduction of IL-6 occurring only just over 20 years ago. Commercially available assays 
have taken time to develop but are now available for many biomarkers, allowing an 
expansion of this research in recent years. Early research often involved small samples 
and there was a need to compare proteins and establish time courses for the rapidly 
changing concentrations in the early post-surgery phase. Nevertheless basic measurement 
properties have not been sufficiently worked out. The reasons for some differences in time 
courses in studies on the same proteins remain unknown. The reasons why response 
magnitudes vary across studies are also not known. In research on muscle injury, 
advantages and disadvantages of cytoplasmic versus contractile apparatus proteins have 
been argued but need to be studied. There are a large number of patient characteristics 
and potential confounds including various drugs that could influence the different 
proteins in different ways. All of these issues require future research. Insufficient 
understanding of these variables could be creating weaker associations with clinical 
criterion variables than might be achievable. 
In applying biomarkers to clinical issues, the most promising findings have been in 
identifying risk of infection with many studies on CRP but few studies of IL-6. While it is 
tempting to conclude that IL-6 is the superior infection marker, more research is needed 
comparing IL-6 to CRP and on the possibility of their combination to improve risk 
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stratification. Further improvement in assays might reveal applications for osteolysis and 
hardware failure but diagnostic accuracy has not been evident thus far. It seems unlikely 
that improvement in blood sampling will change this given that chronic levels are measured 
which should be much less variable than protein concentrations in the early post-surgery 
period. Nevertheless, adjustment for within subject fluctuations to improve baseline 
estimation could be attempted.  
In the early post-operative period, the rapidly changing nature of biomarker concentrations 
is a major challenge. This becomes quite relevant in application to identifying early 
complications that affect length of stay. Given the paucity of research on this issue, there is a 
need for further research. A caveat is that insufficient understanding of the time courses or 
reasons for differences in time courses across studies, and the sources of variance outside of 
injury and inflammation, will reduce the efficiency of that line of research. This probably 
forces such studies to make many serial measures and measure a wide range of potential 
confounds or covariates before simpler models can be trusted. What appears to be emerging 
from the drug research is that there are substantial differences in the effects of different 
pharmacological agents on different proteins. Different antiinflammatories do not affect 
inflammation biomarkers equally. This is worthy of investigation itself, but becomes a 
problem when the absence of a change in a biomarker is interpreted to reflect no clinical 
effect. The use of multiple biomarkers and multiple clinical outcomes will continue to be 
necessary in this line of research.  
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